Related Experiment Video
Updated: Jan 30, 2026

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
Correction to: JAK Inhibitors for Atopic Dermatitis: An Update
Helen He1, Emma Guttman-Yassky2,3
1Department of Dermatology and the Immunology Institute, Icahn School of Medicine at Mount Sinai, 5 E. 98th Street, New York, NY, 10029, USA.
This study identified a previously unrecorded manufacturer for ASN002. Further investigation is needed to confirm the accuracy of this updated information.
Area of Science:
- Biomedical research
- Pharmaceutical manufacturing
Background:
- Accurate documentation of product details is crucial in scientific research.
- Table 1 in the study contains information on various research components, including manufacturer data.
Purpose of the Study:
- To correct an erroneous entry in Table 1 regarding the manufacturer of ASN002.
- To ensure data integrity and accuracy in the research publication.
Main Methods:
- Review of study documentation, specifically Page 7, Table 1.
- Identification of the specific row (ASN002) and column (Manufacturer) requiring correction.
Main Results:
- A discrepancy was found in the reported manufacturer for ASN002.
- The previous entry for the manufacturer has been identified and is noted for correction.
Conclusions:
- Data accuracy is paramount for reproducible scientific findings.
- Correction of this detail will enhance the reliability of the study's data.
Related Concept Videos
Distance Corrections
The JAK-STAT Signaling Pathway
Power Factor Correction
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
NMR Spectrometers: Resolution and Error Correction
Dipeptidyl Peptidase 4 Inhibitors

